Vol.18 No.6

Original Article

Decrease in CD4+CD25+ and CD8+CD28+ T cells in interstitial pneumonitis associated with rheumatic disease

Authors

Akira Katagiri1 , Shinji Morimoto1 , Yutaka Nakiri1 , Souichiro Nakano1 , Akiko Mitsuo1 , Jun Suzuki1 , Hirofumi Amano1 , Kazuhisa Nozawa1 , Masanao Asano1 , Yoshiaki Tokano1 , Hiroshi Hashimoto1 , Yoshinari Takasaki1

  • Department of Internal Medicine and Rheumatology, School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan
Received:

7 February 2008

Accepted:

7 May 2008

Published online:

19 June 2008

Full Text

PDF (member's only)

Abstract

The expression of CD25 or CD28 on T cells was examined in patients with rheumatic diseases associated with interstitial pneumonitis (IP), in order to investigate the conditions of CD4+CD25+ regulatory T cells and CD8+CD28- suppressor T cells. Fifty-five patients with various rheumatic diseases and 23 normal controls were enrolled. CD4+CD25+ T cells of patients with IP were significantly decreased in comparison with non-IP patients, and the ratio of CD8+CD28- T cells in patients with IP was significantly higher than that in non-IP patients or normal controls. These results for CD8+CD28- T cells were in accord with the decrease in CD8+CD28+ T cells, and may be related to activation-induced CD8+CD28+ T-cell death. Thus, the abnormality of CD4+CD25+ regulatory T cells may be related to the pathogenesis of IP, and the survival and activation of CD8+ T cells.

Key words

CD4+CD25+ regulatory T cell - CD8+CD28- suppressor T cell - Interstitial pneumonitis - Rheumatic diseases - CD62L